Q
The startup develops cell detection devices that utilize three-dimensional optical tomography microscopy to enhance the identification of rare circulating tumor cells in blood samples. By minimizing interference from out-of-focus fluorescence, these devices enable early detection of tumor cell heterogeneity, which is critical for timely cancer diagnosis.
Updated 3 months ago
Funding
$760K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops cell detection devices that utilize three-dimensional optical tomography microscopy to enhance the identification of rare circulating tumor cells in blood samples. By minimizing interference from out-of-focus fluorescence, these devices enable early detection of tumor cell heterogeneity, which is critical for timely cancer diagnosis.